Histological and immunohistochemical profiles predict lymph node status in women with low-intermediate risk endometrial cancer

Gynecologic Oncology

Volumn 130, Issue 3, 2013, Pages 457-462

  Ballester, Marcos ^a,b,c   Canlorbe, Geoffroy ^a   Cortez, Annie ^a   Gonin, Julie ^a   Laas, Enora ^a   Bendifallah, Sofiane ^a   Graesslin, Olivier ^d   Daraï, Emile ^a,e  

^a HÔPITAL TENON   (France)

^b INSTITUT UNIVERSITAIRE DE FRANCE   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d HÔPITAL MAISON BLANCHE   (France)

^e CENTRE DE RECHERCHE SAINT ANTOINE   (France)

Author keywords

Endometrial cancer; Histology; Immunohistochemistry; Low intermediate risk; Lymph node metastases; Predictive model

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; CANCER RISK; COHORT ANALYSIS; ENDOMETRIUM CANCER; FEMALE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL;

ENDOMETRIAL CANCER; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LOW/INTERMEDIATE RISK; LYMPH NODE METASTASES; PREDICTIVE MODEL;

BLOOD VESSELS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS;

EID: 84882455916     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.06.001     Document Type: Article

References (35)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
2. N. Colombo, E. Preti, F. Landoni, S. Carinelli, A. Colombo, and C. Marini Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 22 Suppl. 6 2011 vi35 vi39
3. E.K. Nugent, E.A. Bishop, C.A. Mathews, K.M. Moxley, M. Tenney, and R.S. Mannel Do uterine risk factors or lymph node metastasis more significantly affect recurrence in patients with endometrioid adenocarcinoma? Gynecol Oncol 125 2012 94 98
4. A. Mariani, S.C. Dowdy, and K.C. Podratz New surgical staging of endometrial cancer: 20 years later Int J Gynaecol Obstet 105 2009 110 111
5. D.S. Chi, R.R. Barakat, M.J. Palayekar, D.A. Levine, Y. Sonoda, and K. Alektiar The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology Int J Gynecol Cancer 18 2008 269 273
6. P. Benedetti Panici, S. Basile, F. Maneschi, A. Alberto Lissoni, M. Signorelli, and G. Scambia Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial J Natl Cancer Inst 100 2008 1707 1716
7. H. Kitchener, A.M. Swart, Q. Qian, C. Amos, and M.K. Parmar Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study Lancet 373 2009 125 136
8. D. Querleu, F. Planchamp, F. Narducci, P. Morice, F. Joly, and C. Genestie Clinical practice guidelines for the management of patients with endometrial cancer in France: recommendations of the Institut National du Cancer and the Societe Francaise d'Oncologie Gynecologique Int J Gynecol Cancer 21 2011 945 950
9. M. Ballester, G. Dubernard, F. Lecuru, D. Heitz, P. Mathevet, and H. Marret Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO) Lancet Oncol 12 2011 469 476
10. M. Frumovitz, D.K. Singh, L. Meyer, D.H. Smith, I. Wertheim, and E. Resnik Predictors of final histology in patients with endometrial cancer Gynecol Oncol 95 2004 463 468
11. E. Petru, H.J. Luck, G. Stuart, D. Gaffney, D. Millan, and I. Vergote Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system Eur J Obstet Gynecol Reprod Biol 143 2009 69 74
12. T. Song, J.W. Lee, C.H. Choi, T.J. Kim, D.S. Bae, and C.O. Sung Ploidy and S-phase fraction are correlated with lymphovascular space invasion that is predictive of outcomes in endometrial cancer Int J Clin Oncol 17 2012 590 597
13. D.J. Bevitt, I.D. Milton, N. Piggot, L. Henry, M.J. Carter, and G.L. Toms New monoclonal antibodies to oestrogen and progesterone receptors effective for paraffin section immunohistochemistry J Pathol 183 1997 228 232
14. N. Yamauchi, A. Sakamoto, H. Uozaki, K. Iihara, and R. Machinami Immunohistochemical analysis of endometrial adenocarcinoma for bcl-2 and p53 in relation to expression of sex steroid receptor and proliferative activity Int J Gynecol Pathol 15 1996 202 208
15. I. Markova, M. Duskova, M. Lubusky, M. Kudela, J. Zapletalova, and M. Prochazka Selected immunohistochemical prognostic factors in endometrial cancer Int J Gynecol Cancer 20 2010 576 582
16. K. Fukuda, M. Mori, M. Uchiyama, K. Iwai, T. Iwasaka, and H. Sugimori Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma Gynecol Oncol 69 1998 220 225
17. H.C. Nyholm, I.J. Christensen, and A.L. Nielsen Progesterone receptor levels independently predict survival in endometrial adenocarcinoma Gynecol Oncol 59 1995 347 351
18. G. Ferrandina, F.O. Ranelletti, V. Gallotta, E. Martinelli, G.F. Zannoni, and M. Gessi Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer Gynecol Oncol 98 2005 383 389
19. R. Halperin, S. Zehavi, L. Habler, E. Hadas, I. Bukovsky, and D. Schneider Comparative immunohistochemical study of endometrioid and serous papillary carcinoma of endometrium Eur J Gynaecol Oncol 22 2001 122 126
20. V. Jongen, J. Briet, R. de Jong, K. ten Hoor, M. Boezen, and A. van der Zee Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer Gynecol Oncol 44 6 2009 1047 1054
21. G.F. Zannoni, G. Monterossi, I. De Stefano, A. Gargini, M.G. Salerno, and I. Farulla The expression ratios of estrogen receptor alpha (ERalpha) to estrogen receptor beta1 (ERbeta1) and ERalpha to ERbeta2 identify poor clinical outcome in endometrioid endometrial cancer Hum Pathol 2012
22. S. Kounelis, N. Kapranos, E. Kouri, D. Coppola, H. Papadaki, and M.W. Jones Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature Mod Pathol 13 2000 379 388
23. A. Alkushi, M. Kobel, S.E. Kalloger, and C.B. Gilks High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes Int J Gynecol Pathol 29 2010 343 350
24. C. Zhu, J. Luo, H. Shi, X. Xie, and Z. Ding Expression of tubulin, p53, ki67, receptors for estrogen, and progesterone in endometrial cancer Eur J Gynaecol Oncol 30 2009 514 517
25. P. Jalava, T. Kuopio, R. Huovinen, J. Laine, and Y. Collan Immunohistochemical staining of estrogen and progesterone receptors: aspects for evaluating positivity and defining the cutpoints Anticancer Res 25 2005 2535 2542
26. B.A. Clarke, and C.B. Gilks Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type J Clin Pathol 63 2010 410 415
27. F. Simpkins, A. Papadia, C. Kunos, C. Michener, H. Frasure, and F. AbuShahin Patterns of recurrence in stage I endometrioid endometrial adenocarcinoma with lymphovascular space invasion Int J Gynecol Cancer 23 2013 98 104
28. C. Zhang, C. Wang, and W. Feng Clinicopathological risk factors for pelvic lymph node metastasis in clinical early-stage endometrioid endometrial adenocarcinoma Int J Gynecol Cancer 22 2012 1373 1377
29. K. May, A. Bryant, H.O. Dickinson, S. Kehoe, and J. Morrison Lymphadenectomy for the management of endometrial cancer Cochrane Database Syst Rev 2010 CD007585
30. S. Bendifallah, A.S. Genin, I. Naoura, N. Chabbert Buffet, F. Clavel Chapelon, and B. Haddad A nomogram for predicting lymph node metastasis of presumed stage I and II endometrial cancer Am J Obstet Gynecol 207 2012 197e1 197e8
31. R.E. Bristow, M.L. Zahurak, C.J. Alexander, R.C. Zellars, and F.J. Montz FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival Int J Gynecol Cancer 13 2003 664 672
32. Y. Todo, H. Kato, M. Kaneuchi, H. Watari, M. Takeda, and N. Sakuragi Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis Lancet 375 2010 1165 1172
33. R.A. Nout, V.T. Smit, H. Putter, I.M. Jurgenliemk-Schulz, J.J. Jobsen, and L.C. Lutgens Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial Lancet 375 2010 816 823
34. H. Yabushita, M. Shimazu, H. Yamada, K. Sawaguchi, M. Noguchi, and M. Nakanishi Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer Gynecol Oncol 80 2001 139 144
35. N.R. Abu-Rustum, J.D. Gomez, K.M. Alektiar, R.A. Soslow, M.L. Hensley, and M.M. Leitao Jr. The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes Gynecol Oncol 115 2009 236 238